Related Experiment Video
Updated: Jul 16, 2025

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
The human leukemic oncogene MLL-AF4 promotes hyperplastic growth of hematopoietic tissues in Drosophila larvae
Julie A Johannessen1,2,3, Miriam Formica1,2,3, Aina Louise C Haukeland1,2,3
1Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Abstract:
MLL-rearranged (MLL-r) leukemias are among the leukemic subtypes with poorest survival, and treatment options have barely improved over the last decades. Despite increasing molecular understanding of the mechanisms behind these hematopoietic malignancies, this knowledge has had poor translation into the clinic. Here, we report a Drosophila melanogaster model system to explore the pathways affected in MLL-r leukemia. We show that expression of the human leukemic oncogene MLL-AF4 in the Drosophila hematopoietic system resulted in increased levels of circulating hemocytes and an enlargement of the larval hematopoietic organ, the lymph gland. Strikingly, depletion of Drosophila orthologs of known interactors of MLL-AF4, such as DOT1L, rescued the leukemic phenotype. In agreement, treatment with small-molecule inhibitors of DOT1L also prevented the MLL-AF4-induced leukemia-like phenotype. Taken together, this model provides an in vivo system to unravel the genetic interactors involved in leukemogenesis and offers a system for improved biological understanding of MLL-r leukemia.
Insights
A new Drosophila model for MLL-rearranged (MLL-r) leukemia reveals DOT1L as a key therapeutic target. Inhibiting DOT1L reversed leukemia development in this model, offering hope for improved MLL-r leukemia treatments.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- MLL-rearranged (MLL-r) leukemias have poor survival rates with limited treatment advancements.
- Despite molecular insights, translating this knowledge into clinical applications for MLL-r leukemia remains a challenge.
Purpose of the Study:
- To establish a Drosophila melanogaster model for investigating MLL-r leukemia pathways.
- To identify potential therapeutic targets for MLL-r leukemia.
Main Methods:
- Expression of human MLL-AF4 oncogene in Drosophila hematopoietic system.
- Depletion of Drosophila orthologs of MLL-AF4 interactors, including DOT1L.
- Treatment with small-molecule inhibitors of DOT1L.
Main Results:
- MLL-AF4 expression in Drosophila caused increased hemocytes and lymph gland enlargement, mimicking leukemia.
- Depleting DOT1L or inhibiting it with small molecules rescued the MLL-AF4-induced leukemia phenotype.
- The Drosophila model successfully recapitulated key aspects of MLL-r leukemia.
Conclusions:
- The Drosophila model provides a valuable in vivo system for studying MLL-r leukemogenesis.
- DOT1L is a critical interactor in MLL-r leukemogenesis and a promising therapeutic target.
- This model can facilitate the discovery of novel genetic interactors and improve biological understanding of MLL-r leukemia.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Differentiation of Common Myeloid Progenitor Cells

